Skip to search formSkip to main contentSkip to account menu

Ritonavir

Known as: Ritonavirum, RTV, RIT 
A drug used to treat infection with HIV (the virus that causes AIDS). It is also being studied in the treatment of some types of cancer. Ritonavir… 
National Institutes of Health

Related topics

Related topics

45 relations
12 HR Propafenone Hydrochloride 225 MG Extended Release Oral CapsuleAmiodaroneAstemizoleCisapride

Broader (3)

Cytochrome P-450 CYP3A InhibitorsHIV Protease InhibitorsThiazoles

Narrower (2)

Norvirlopinavir-ritonavir drug combination

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma
PurposeRadioimmunotherapy (RIT) is a new treatment option for patients with non-Hodgkin lymphoma (NHL). Response to RIT currently… 
Highly Cited
2006
Highly Cited
2006
HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment.
Highly Cited
2003
Highly Cited
2003
Simultaneous determination of nine antiretroviral compounds in human plasma using liquid chromatography.
Review
2002
Review
2002
Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice.
Radioimmunotherapy (RIT) is a new treatment modality for B-cell non-Hodgkin's lymphoma (NHL). Recent clinical trials have clearly… 
Highly Cited
2002
Highly Cited
2002
Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium‐DOTA‐peptide‐ChL6
Therapy for prostate cancer in the PC3 tumor‐nude mouse model with 90yttrium‐(90Y)‐DOTA‐peptide‐ChL6 (5.55 MBq;150 μCi) has… 
Review
1999
Review
1999
Restoration of the immune system with anti-retroviral therapy.
Highly Cited
1999
Highly Cited
1999
Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir.
OBJECTIVES The effectiveness of a second protease inhibitor in patients who failed an initial protease inhibitor is unclear but… 
Highly Cited
1999
Highly Cited
1999
Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting.
OBJECTIVE To determine whether baseline drug resistance assays could help to predict treatment failure with the protease… 
Highly Cited
1998
Highly Cited
1998
Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir.
Inhibiting human immunodeficiency virus (HIV) replication with potent antiretroviral therapy may result in improved immune… 
Review
1992
Review
1992
Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam irradiation.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)